Please login to the form below

Not currently logged in
Email:
Password:

Symdeko

This page shows the latest Symdeko news and features for those working in and with pharma, biotech and healthcare.

Vertex scores FDA approval for CF triple therapy Trikafta

Vertex scores FDA approval for CF triple therapy Trikafta

and Symkevi/Symdeko (tezacaftor/ivacaftor) – which can treat around half of patients. ... The list price of $311, 000 is more than Leerink analyst Geoffrey Porges' prediction that the triple therapy could be priced similarly to Symdeko, which costs $233

Latest news

More from news
Approximately 1 fully matching, plus 7 partially matching documents found.

Latest Intelligence

More from intelligence
Approximately 0 fully matching, plus 1 partially matching documents found.

Subscribe to our email news alerts

Featured jobs

PMHub

Add my company
Impetus Digital

Impetus Digital has offered virtual advisory boards, clinical trial investigator consortiums, co-author publication working groups, steering committees, and medical education...

Latest intelligence

William Kilgallon
How the Royal Society’s EiR programme can help to drive UK innovation
...
Box 1
Strategic commitment
...
KOL Ambassador Program & Podcast Creation: A Customer Story
...